The Hormone Powering Weight Loss Medications In the world of modern medicine, few discoveries have generated as much excitement in recent years as glucagon-like peptide-1 (GLP-1)
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of medications that are effective treatment for patients with type 2 diabetes mellitus (T2DM) and weight control by stimulating insulin secretion, suppressing glucagon secretion, delaying gastric emptying and decreasing appetite. To investigate whether GLP-1RAs might have a positive impact in patients with knee OA, Zhu and colleagues analyzed data from a prospective, observational, multicenter study called the Shanghai Osteoarthritis Cohort
For eligible adults, its a simple way to explore GLP-1 therapy with medical guidance built in from the start
The formulation of exenatide ER comprises the encapsulation of exenatide IR peptides within 0.06 mm-diameter injectable microspheres made of poly-(D,L lactide-co-glycolide) a biodegradable medical polymer enabling controlled, gradual drug release over an extended period (89)
[3] Obesity-related respiratory conditions: Patients with obesity commonly have underlying respiratory disorders that may become more apparent during treatment
Has constipation changed scale weight
